During the Hematology Week organized by the Virgen de la Arrixaca University Clinical Hospital, the European project NANEMIAR was presented. This is a cutting-edge research initiative focused on addressing congenital anemia through innovative technologies. 

The project is led by Dr. Pérez Oliva from OcaILab  (FFIS–IMIB), in close collaboration with the Hematology Department of the Virgen de la Arrixaca University Clinical Hospital, headed by Dr. Vanesa Roldán (Murcia Health Service / Regional Ministry of Health). This alliance strengthens the commitment to translational research and cooperation between clinical and scientific groups at the European level. 

The presentation of NANEMIAR in this context highlighted the importance of innovation and multidisciplinary work in advancing the diagnosis and treatment of hematological diseases.